Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers.

Novais T, Duclos A, Varin R, Lopez I, Chamouard V.

Int J Clin Pharm. 2016 Feb;38(1):61-9.


Switching from an anti-TNF monoclonal antibody to soluble TNF-receptor yields better results than vice versa: An observational retrospective study of 72 rheumatoid arthritis switchers.

Lequerré T, Farran É, Ménard JF, Kozyreff-Meurice M, Vandhuick T, Tharasse C, Pouplin S, Daragon A, Le Loët X, Varin R, Vittecoq O.

Joint Bone Spine. 2015 Oct;82(5):330-7. doi: 10.1016/j.jbspin.2015.01.021. Epub 2015 Apr 10.


Impact of recommendations on crushing medications in geriatrics: from prescription to administration.

Bourdenet G, Giraud S, Artur M, Dutertre S, Dufour M, Lefèbvre-Caussin M, Proux A, Philippe S, Capet C, Fontaine-Adam M, Kadri K, Landrin I, Gréboval E, Touflet M, Nanfack J, Tharasse C, Varin R, Rémy E, Daouphars M, Doucet J.

Fundam Clin Pharmacol. 2015 Jun;29(3):316-20. doi: 10.1111/fcp.12116. Epub 2015 Apr 15.


Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

Huang L, Hu C, DI Benedetto M, Varin R, Liu J, Jin J, Wang L, Vannier JP, Janin A, Lu H, Li H.

Oncol Lett. 2015 Mar;9(3):1287-1292. Epub 2014 Dec 22.


Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release.

Laurent M, Joimel U, Varin R, Cazin L, Gest C, Le-Cam-Duchez V, Jin J, Liu J, Vannier JP, Lu H, Soria J, Li H, Soria C.

Exp Hematol Oncol. 2014 Dec 17;3(1):30. doi: 10.1186/2162-3619-3-30. eCollection 2014.


Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.

Huang L, Hu C, Di Benedetto M, Varin R, Liu J, Wang L, Vannier JP, Jin J, Janin A, Lu H, Li H.

Onco Targets Ther. 2014 Dec 4;7:2249-55. doi: 10.2147/OTT.S67251. eCollection 2014.


New combinational assay using soluble fibrin and d-dimer determinations: a promising strategy for identifying patients with suspected venous thromboembolism.

Mirshahi S, Soria C, Kouchakji B, Kierzek G, Borg JY, Varin R, Chidiac J, Drouet L, Mirshahi M, Soria J.

PLoS One. 2014 Mar 24;9(3):e92379. doi: 10.1371/journal.pone.0092379. eCollection 2014.


The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.

Dulong C, Fang YJ, Gest C, Zhou MH, Patte-Mensah C, Mensah-Nyagan AG, Vannier JP, Lu H, Soria C, Cazin L, Mei YA, Varin R, Li H.

Int J Oncol. 2014 Feb;44(2):539-47. doi: 10.3892/ijo.2013.2214. Epub 2013 Dec 10.


Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy.

Huang L, Perrault C, Coelho-Martins J, Hu C, Dulong C, Varna M, Liu J, Jin J, Soria C, Cazin L, Janin A, Li H, Varin R, Lu H.

J Hematol Oncol. 2013 Jul 9;6:49. doi: 10.1186/1756-8722-6-49.


Photocatalytic activity of hydrogenated TiO2.

Leshuk T, Parviz R, Everett P, Krishnakumar H, Varin RA, Gu F.

ACS Appl Mater Interfaces. 2013 Mar;5(6):1892-5. doi: 10.1021/am302903n. Epub 2013 Mar 12.


Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.

Gest C, Joimel U, Huang L, Pritchard LL, Petit A, Dulong C, Buquet C, Hu CQ, Mirshahi P, Laurent M, Fauvel-Lafève F, Cazin L, Vannier JP, Lu H, Soria J, Li H, Varin R, Soria C.

BMC Cancer. 2013 Feb 6;13:63. doi: 10.1186/1471-2407-13-63.


Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia.

Daouphars M, Ouvry M, Lenain P, Rouvet J, Jardin F, Bubenheim M, Varin R.

Pharmacotherapy. 2013 Feb;33(2):152-6. doi: 10.1002/phar.1174. Epub 2013 Jan 28.


Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.

Varin R, Mirshahi S, Mirshahi P, Klein C, Jamshedov J, Chidiac J, Perzborn E, Mirshahi M, Soria C, Soria J.

Thromb Res. 2013 Mar;131(3):e100-9. doi: 10.1016/j.thromres.2012.11.029. Epub 2013 Jan 11.


[Crushing drugs in geriatric units: an "handicraft" practice with frequent errors which imposed recommendations].

Caussin M, Mourier W, Philippe S, Capet C, Adam M, Reynero N, Jouini C, Colombier AS, Kadri K, Landrin I, Gréboval E, Rémy E, Marc F, Touflet M, Wirotius F, Delabre N, Le Hiress C, Rorteau V, Vimard M, Dufour M, Tharasse C, Dieu B, Varin R, Doucet J.

Rev Med Interne. 2012 Oct;33(10):546-51. doi: 10.1016/j.revmed.2012.05.014. Epub 2012 Jun 15. French.


Knowledge assessment and information needs of oncology nurses regarding inpatient medication.

Daouphars M, Magali A, Bertrand E, Basuyau F, Violette S, Varin R.

Clin J Oncol Nurs. 2012 Apr;16(2):182-7. doi: 10.1188/12.CJON.182-187.


Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.

Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, Chidiac J, Poletto B, Vannier JP, Varin R, Mirshahi M, Cazin L, Pujade-Lauraine E, Soria J, Soria C.

Cancer Lett. 2012 Apr 28;317(2):207-17. doi: 10.1016/j.canlet.2011.11.026. Epub 2011 Nov 25.


Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.

Joimel U, Gest C, Soria J, Pritchard LL, Alexandre J, Laurent M, Blot E, Cazin L, Vannier JP, Varin R, Li H, Soria C.

BMC Cancer. 2010 Jul 17;10:375. doi: 10.1186/1471-2407-10-375.


[An update on the use of tissue adhesives in ophthalmology].

Vera L, Benzerroug M, Gueudry J, Varin R, Haghighat S, Gérard G, Muraine M.

J Fr Ophtalmol. 2009 Apr;32(4):290-305. doi: 10.1016/j.jfo.2009.01.008. Epub 2009 Mar 19. Review. French.


Vasculogenic mimicry of acute leukemic bone marrow stromal cells.

Mirshahi P, Rafii A, Vincent L, Berthaut A, Varin R, Kalantar G, Marzac C, Calandini OA, Marie JP, Soria C, Soria J, Mirshahi M.

Leukemia. 2009 Jun;23(6):1039-48. doi: 10.1038/leu.2009.10. Epub 2009 Apr 2.

Items per page

Supplemental Content

Write to the Help Desk